S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
ACB   1.89 (-5.03%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
PRI   119.08 (-2.82%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
ACB   1.89 (-5.03%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
PRI   119.08 (-2.82%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
ACB   1.89 (-5.03%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
PRI   119.08 (-2.82%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
S&P 500   3,243.63 (-1.57%)
DOW   28,535.80 (-1.57%)
QQQ   218.10 (-2.07%)
AAPL   308.95 (-2.94%)
FB   214.87 (-1.41%)
MSFT   162.28 (-1.67%)
GOOGL   1,431.73 (-2.35%)
AMZN   1,828.34 (-1.79%)
CGC   21.56 (-4.81%)
NVDA   240.20 (-4.10%)
BABA   205.47 (-3.87%)
MU   55.41 (-4.07%)
GE   11.44 (-2.31%)
TSLA   558.02 (-1.20%)
AMD   49.26 (-2.16%)
T   38.25 (-0.65%)
ACB   1.89 (-5.03%)
F   8.89 (-1.22%)
NFLX   342.88 (-2.91%)
PRI   119.08 (-2.82%)
BAC   32.85 (-2.06%)
DIS   135.90 (-2.98%)
GILD   63.83 (+1.08%)
Log in

NASDAQ:SIBN - SI-Bone Stock Price, Forecast & News

$22.48
+0.61 (+2.79 %)
(As of 01/27/2020 04:00 PM ET)
Today's Range
$21.06
Now: $22.48
$22.99
50-Day Range
$18.18
MA: $20.96
$22.48
52-Week Range
$14.08
Now: $22.48
$22.99
Volume266,241 shs
Average Volume272,594 shs
Market Capitalization$562.11 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.47
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SIBN
CUSIPN/A
CIKN/A
Phone408-207-0700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$55.38 million
Book Value$3.71 per share

Profitability

Net Income$-17,450,000.00

Miscellaneous

Employees183
Market Cap$562.11 million
Next Earnings Date3/5/2020 (Estimated)
OptionableNot Optionable

Receive SIBN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter.


SI-Bone (NASDAQ:SIBN) Frequently Asked Questions

What is SI-Bone's stock symbol?

SI-Bone trades on the NASDAQ under the ticker symbol "SIBN."

How were SI-Bone's earnings last quarter?

SI-Bone Inc (NASDAQ:SIBN) issued its quarterly earnings data on Monday, November, 11th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.36) by $0.10. The firm had revenue of $16.18 million for the quarter. SI-Bone had a negative return on equity of 42.29% and a negative net margin of 54.85%. View SI-Bone's Earnings History.

When is SI-Bone's next earnings date?

SI-Bone is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for SI-Bone.

What guidance has SI-Bone issued on next quarter's earnings?

SI-Bone issued an update on its FY 2019 Pre-Market earnings guidance on Thursday, January, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $67-67.3 million, compared to the consensus revenue estimate of $66.19 million.

What price target have analysts set for SIBN?

2 Wall Street analysts have issued 1 year target prices for SI-Bone's shares. Their forecasts range from $27.00 to $27.00. On average, they anticipate SI-Bone's stock price to reach $27.00 in the next year. This suggests a possible upside of 20.1% from the stock's current price. View Analyst Price Targets for SI-Bone.

What is the consensus analysts' recommendation for SI-Bone?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-Bone in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SI-Bone.

Has SI-Bone been receiving favorable news coverage?

News headlines about SIBN stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. SI-Bone earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for SI-Bone.

Who are some of SI-Bone's key competitors?

What other stocks do shareholders of SI-Bone own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-Bone investors own include Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Cisco Systems (CSCO), CSX (CSX), CVS Health (CVS), Procter & Gamble (PG) and Johnson & Johnson (JNJ).

Who are SI-Bone's key executives?

SI-Bone's management team includes the folowing people:
  • Mr. Jeffrey W. Dunn, CEO, Pres & Chairman (Age 63)
  • Dr. Mark A. Reiley M.D., Founder & Director (Age 68)
  • Ms. Laura A. Francis, Chief Financial Officer (Age 52)
  • Mr. Anthony J. Recupero, Chief Commercial Officer (Age 61)
  • Dr. Scott A. Yerby, Chief Technology Officer (Age 51)

When did SI-Bone IPO?

(SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Who are SI-Bone's major shareholders?

SI-Bone's stock is owned by many different of retail and institutional investors. Top institutional shareholders include California Public Employees Retirement System (0.11%). Company insiders that own SI-Bone stock include Anthony J Recupero, David P Bonita, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling. View Institutional Ownership Trends for SI-Bone.

Which institutional investors are buying SI-Bone stock?

SIBN stock was acquired by a variety of institutional investors in the last quarter, including California Public Employees Retirement System. Company insiders that have bought SI-Bone stock in the last two years include David P Bonita and Skyline Venture Partners V Lp. View Insider Buying and Selling for SI-Bone.

How do I buy shares of SI-Bone?

Shares of SIBN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is SI-Bone's stock price today?

One share of SIBN stock can currently be purchased for approximately $22.48.

How big of a company is SI-Bone?

SI-Bone has a market capitalization of $562.11 million and generates $55.38 million in revenue each year. The company earns $-17,450,000.00 in net income (profit) each year or ($0.71) on an earnings per share basis. SI-Bone employs 183 workers across the globe.View Additional Information About SI-Bone.

What is SI-Bone's official website?

The official website for SI-Bone is http://si-bone.com/.

How can I contact SI-Bone?

SI-Bone's mailing address is 471 EL CAMINO REAL SUITE 101, SANTA CLARA CA, 95050. The company can be reached via phone at 408-207-0700 or via email at [email protected]


MarketBeat Community Rating for SI-Bone (NASDAQ SIBN)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  137
MarketBeat's community ratings are surveys of what our community members think about SI-Bone and other stocks. Vote "Outperform" if you believe SIBN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIBN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: What is a resistance level?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel